Additionally, Yousefi et al., reported a positive correlation between expression level of FCRL1 and many clinicopathological criteria of large B-cell lymphoma patients, such as “tumor size, stage of disease, PS at diagnosis, and IPI scores” [21]. Here, FCRL1 is linked to neoplasm.